NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Florida business leaders launched the “Ambition Accelerated” campaign, backed by Ken Griffin and Stephen Ross, to attract even more CEOs and investors to South Florida.Read More